Aptevo Therapeutics Statistics
NASDAQ: APVOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.80-0.045 (-2.45%)
Market open · Delayed 15 min · as of Oct 8, 9:47 AM ET
Aptevo Therapeutics by the numbers
Aptevo Therapeutics has a market capitalization of $3.2 million based on 1.81M shares outstanding. Its trailing P/E ratio is 0.0. The stock trades 29.6% below its 50-day average and 65.5% below its 200-day average.
Average daily trading volume is 93.62K shares, or about $168,053 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
APVO valuation vs. peer median
| Metric | APVO | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.25M | $3.32M | -2% |
| Avg. volume | 93.62K | 300.88K | -69% |
Peer median across 8 companies: MBIO, CVKD, KAPA, REVB, XRTX, HCWB, ONCO, CMND.
Valuation
- Market cap
- $3.25M
- P/E (TTM)
- 0.03
- EPS (TTM)
- $66.96
- Shares outstanding
- 1.81M
Price and trading
- Previous close
- 1.84
- Open
- 1.77
- Day range
- 1.77 – 1.80
- 52-week range
- 1.37 – 33.12
- Beta
- —
- Volume
- 4.55K
- Average volume
- 93.62K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 3.25M
- Pe
- 0.03
- Forward Pe
- -0.17
- Eps
- 66.96
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 33.12
- Week52 Low
- 1.37
- Avg Volume
- 93,623.00
- Shares Outstanding
- 1.81M
- Ma50
- 2.55
- Ma200
- 5.20
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -94.58%
- Pct From52w Low
- 31.02%